Skip to main content
Premium Trial:

Request an Annual Quote

Certara, Thomson Reuters Ink Data Access Agreement


Certara said this week that it is partnering with Thomson Reuters to provide customers of its D360 software solution with access to content contained in Thomson Reuters' Cortellis for Informatics system.

The D360 solution provides tools for pharmaceutical companies to query, analyze, and visualize drug discovery and development data. Cortellis for Informatics provides information such as published experimental pharmacology, pharmacokinetic, and pharmacodynamic results; clinical trial protocols and outcomes; competitive intelligence; patent information; and pharma company press releases and presentations.

Among other benefits, the partnership will "enable our mutual customers to integrate Thomson Reuters' authoritative content with other proprietary and public data that they have integrated via the D360 platform," according to Joseph Donahue, senior vice president at Thomson Reuters.

It will also provide D360's users with "data views that present curated public data alongside a company's internal proprietary data," Jonathan Feldmann, vice president, scientific informatics at Certara, said in a statement.

The financial details of the agreement were not disclosed.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.